Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Fostamatinib and efgartigimod: novel agents in the treatment of ITP
1:54
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Fostamatinib and efgartigimod: novel agents in the treatment of ITP
1:54
|
Dr. Fertrin on the Potential of Fostamatinib in Chronic ITP
1:24
|
Michael Boxer, MD, on the effectiveness of fostamatinib in the maintenance of ITP responses
2:49
|
Investigating the Use of Fostamatinib in ITP
9:47
|
Novel investigational drugs and promising therapies for immune thrombocytopenia
1:59
|
What is new in ITP? Prof. David Kuter
20:03
|
Fostamatinib(R788) is a prodrug of the spleen
0:31
|
Recent advances in the mechanism & treatment of Immune Thrmobocytopenia
2:06:03
|
Additional Advances in Immune Thrombocytopenia Research and Clinical Trials
9:42
|
Dr.Gobind Rai Garg discusses the topic - Fostamatinib
2:18
|
Treating Persistent/Chronic ITP Current Care, Future Potential
45:50
|
Current unmet needs in ITP: impaired quality of life & chronic disorders
2:06
|
Modern Management of ITP: Thinking Beyond the Conventional Therapies
33:06
|
🚩 Common Mistakes to Avoid When Navigating SSDI with Chronic Thrombocytopenia! 🚫
0:26
|
What has changed in ITP over the last 20 years Professor David Kuter
26:22
|
Cure of chronic ITP-IMMUNE THROMBOCYTOPENIA
20:01
|
Hematology Breakout Session
41:53
|
Thrombocytopenia disease 🦠
0:27
|
Immune Thrombocytopenia - 6 June 2020
2:10:11
|
Efficacité de la splénectomie dans le PTI à l'ère des ARTPO et des ANTI-CD20
3:11
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
